Skip to main navigation Skip to search Skip to main content

Reconstructing the angiome: A new platform for characterizing disease progreßion and drug efficacy

  • Pavel Govyadinov
  • , Jiaming Guo
  • , Leila Saadatifard
  • , Camille Artur
  • , Jason Eriksen
  • , Guoning Chen
  • , David Mayerich

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

A comprehensive understanding of microvascular networks is required to generate platforms that track treatment efficacy. Current approaches are labor intensive and limited to small tißue volumes. In this work we describe an acquisition and segmentation framework for low-cost imaging and microvascular modeling at resolution comparable to confocal with data rates comparable to light-sheet microscopy. Segmentation is performed using a GPU-based method that extracts microvascular structure and connectivity embedded in these images. The microvasculature network is stored such that the graph [G = V, E] structure can be exploited to quantify large-scale angiomes and facilitate data mining at the terabyte scale.

Original languageEnglish (US)
Title of host publicationDesign and Quality for Biomedical Technologies XIII
EditorsJeeseong Hwang, Gracie Vargas
PublisherSPIE
ISBN (Electronic)9781510632257
DOIs
StatePublished - 2020
Externally publishedYes
EventDesign and Quality for Biomedical Technologies XIII 2020 - San Francisco, United States
Duration: Feb 1 2020Feb 3 2020

Publication series

NameProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume11231
ISSN (Print)1605-7422

Conference

ConferenceDesign and Quality for Biomedical Technologies XIII 2020
Country/TerritoryUnited States
CitySan Francisco
Period2/1/202/3/20

Keywords

  • Three-dimensional microscopy

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Atomic and Molecular Physics, and Optics
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Reconstructing the angiome: A new platform for characterizing disease progreßion and drug efficacy'. Together they form a unique fingerprint.

Cite this